Use of the tumor necrosis factor-blockers for Crohn's disease

Table 25 Reduction (%) of health service utilization in Crohn's disease patients treated with Infliximab

	All CD patients[180]	CD fistula patients
		(Rubenstein et al[180])	(Harrison et al[181])
ER visits	66	64	372
All surgery	38	66
GI surgery	18	59
Hospitalizations		59	37
Endoscopies	43		52
Radiographs	12	40	58-147
Outpatient visits	16	27	22-33

CD: Crohn's disease; ER: Emergency Room; GI: Gastrointestinal.